Moreover, Western blotting revealed that compared with siNC-Mφs, siMCPIP1-Mφs were inferior in suppressing bortezomib-induced activation and cleavage of caspase-3 and PARP in MM cells (Fig. 5c). The gene discussed is CASP3; the disease is Miyoshi myopathy.